Outsourcing Provides Optimal use of Screening Library

Pivot Park Screening Centre (PPSC, Oss, Netherlands) has outsourced management of its screening collection, containing over 300,000 compounds, to BioAscent Discovery which offers expertise in finding optimal use of compounds while preserving their quality.

BioAscent’s Newhouse facility offers a scalable and highly secure infrastructure for storage of compounds in solid and liquid formats and numerous tube and microplate types, from ambient to -20°C. Its reformatting capabilities have already transferred 233,000 aliquots of DMSO stock solutions from microplates into individual tubes, enabling PPSC to cherry pick “hit” compounds following primary ultra-high throughput screening and to confirm and validate their activity on the target. PPSC will also be able to undertake follow up assays faster than before.

Commenting on the agreement, Mirjam Mol-Arts MD, PPSC’s CEO said: “We want to focus on our core areas of expertise, accelerating drug discovery via ultra-high throughput screening and assay development using our leading-edge infrastructure and in-depth experience. By outsourcing the management of our collection to BioAscent we have been able to benefit from their expertise and specialised equipment. This has helped us optimise the use of our extensive compound collection while preserving its integrity and quality, in turn enabling us to offer our customers an even more effective, flexible and cost-efficient service.”